Loading company…
OceansBio develops an AI-based electroceutical solution for epilepsy.
OceansBio develops electronic treatment technology for epilepsy. It also plans prototype development and clinical trials for electronic drugs targeting depression and epilepsy. Founded in 2018, the company is based in Gyeongsangnam-do, South Korea. It raised pre-series A funding in May 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in